Author:
Toga Tetsuo,Kohmura Yumi,Kawatsu Ryoichi
Publisher
Japanese Pharmacological Society
Subject
Pharmacology,Molecular Medicine
Reference14 articles.
1. 1 FDA Talk Paper. Food and Drug Administration, U.S. Department of Health and Human Services. Janssen Pharmaceutica stops marketing cisapride in the US. T00-14, March 23, 2000. http://www.fda.gov/bbs/topics/ANSWERS/ANS01007.html.
2. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
3. A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel
4. QT interval prolongation by noncardiovascular drugs: A proposed assessment strategy
5. 5 ICH S7B Guideline. The non-clinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. May 12, 2005. http://www.ich.org/LOB/media/MEDIA2192.pdf
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献